2 July 2020
It goes without saying that the coronavirus pandemic has had an unprecedented impact on economies and industries worldwide, but within the pharmaceutical space, Covid-19 has completely re-shaped the clinical supply...
29 June 2020
Covid-19 drug studies could highlight speed, flexibility and reduced risk of virtual clinical trials
After announcing a partnership to assess the safety of potential Covid-19 drugs, TRHC and Regence bosses discuss the benefits offered by virtual clinical trials
24 June 2020
Outsourcing is an important means for clinical trial sponsors to bring in outside expertise, from full-service clinical research organisations to smaller functional service providers. Here, Arena International portfolio director Alexander...
19 June 2020
Having grown into one of the biggest companies in the biotech sphere since its inception in 1988, Regeneron is now working to develop a Covid-19 treatment
18 June 2020
Major global events such as the ongoing Covid-19 pandemic can cause significant problems for clinical trials and pharma research programmes. Oncoinvent head of clinical operations Helén Johansen Blanco shares her...
16 June 2020
What can the blockchain offer to time- and cost-intensive modern clinical trials? Novapeutics CEO Frank Leu reviews today's standard clinical trial flow and how blockchain technologies could provide a much-needed...
15 June 2020
FibroGen recently announced enrolment of patients in a clinical study of its antibody drug pamrevlumab as a potential Covid-19 treatment
8 June 2020
Alongside Pfizer, Merck, Johnson & Johnson and AstraZeneca, Moderna was recently selected as a Covid-19 vaccine 'finalist' in the US
2 June 2020
Hydroxychloroquine, a chloroquine drug, has temporarily been dropped from global WHO trials for Covid-19 treatments due to safety concerns
29 May 2020
The RECOVERY and ACCORD studies taking place across the UK right now are some of the biggest clinical trials for Covid-19 treatments anywhere in the world